Certara IQ™ Global Roadshow
Certara IQ™ is going on the road. From APAC to Europe to North America, our…
Certara2026 年 2 月 12 日
Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis
Anti-PD-1 and anti-PD-L1 antibodies have transformed cancer immunotherapy, yet clinical meta-analyses suggest differences in efficacy…
Certara2026 年 2 月 11 日
How quantitative systems pharmacology addresses key challenges in Alzheimer’s drug development
Quantitative Systems Pharmacology (QSP) helps address key challenges in Alzheimer’s disease drug development, including tau…
Certara2026 年 2 月 2 日
First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies
Learn how QSP modeling enabled safe, data-driven FIH dose prediction for the trispecific T-cell activator…
Certara2025 年 12 月 16 日
QSP Workshop 2026 in Japan & Korea – Mastering Scalable AI-enabled QSP modeling software, Certara IQ™
Japan: 2026 年 2 月 26 日 - 1:00 - 5:00 pm | Korea: 2026 年 3 月 4 日, 星期三…
Certara2025 年 12 月 9 日
Quantitative systems pharmacology modeling to support the preclinical development of radiopharmaceuticals
Quantitative Systems Pharmacology (QSP) modeling tackles preclinical radiopharmaceuticals development challenges, from design to dose optimization.
Certara2025 年 11 月 14 日
ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™
At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…
Certara2025 年 11 月 13 日
De-Risking Drug Design: How Early Feasibility Assessment Transforms Biotherapeutic Development
Learn how Early Feasibility Assessment and QSP modeling improve drug design, de-risk feasibility studies, &…
Certara2025 年 11 月 7 日
